MONDAY, April 7, 2025 (HealthDay News) — The rates of respondent dissatisfaction with current hidradenitis suppurativa (HS) treatment options are high, likely due to undertreatment with available therapies, according to study published in the April issue of the Journal of Drugs in Dermatology. Andeulazia Murdock, from the George Washington School of Medicine and Health Sciences […]
The post Rates of Dissatisfaction High for Hidradenitis Suppurativa Care first appeared on Physician’s Weekly.
